Weight loss drug may weaken muscles in seniors, new study warns

NCT ID NCT06811324

Recruiting now Knowledge-focused Sponsor: The University of Texas Health Science Center at San Antonio Source: ClinicalTrials.gov ↗

First seen Jan 17, 2026 · Last updated Jun 16, 2026 · Updated 19 times

Summary

This study looks at how tirzepatide, a weight-loss drug, affects muscle mass and strength in adults aged 50 and older with obesity. Researchers want to know if losing weight with this drug also causes harmful muscle loss that could lead to frailty. Twenty participants will take tirzepatide for 6 months and have their muscle, strength, and walking ability measured. The goal is to better understand the risks and benefits for older adults using this medication.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Texas Health Science Center at San Antonio
RECRUITING

San Antonio, Texas, 78229, United States

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CARDIOVASCULAR FUNCTION GLP - 1 OBESITY PREVENTION SARCOPENIA IN ELDERLY WEIGHT LOSS

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

OBESITY